Formidable Asset Management, LLC Mereo Biopharma Group PLC Transaction History

Formidable Asset Management, LLC

  • $609 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$1.15 - $1.67 $381,701 - $554,296
331,914 New
331,914 $428,000
Q1 2023

May 09, 2023
BUY
$0.71 - $1.22 $31,122 - $53,477
43,834 Added 15.22%
331,914 $234,000
Q4 2022

Feb 07, 2023
BUY
$0.5 - $1.01 $3,131 - $6,324
6,262 Added 2.22%
288,080 $216,000
Q3 2022

Nov 14, 2022
BUY
$0.82 - $1.73 $5,134 - $10,833
6,262 Added 2.27%
281,818 $242,000
Q2 2022

Aug 16, 2022
BUY
$0.33 - $1.69 $90,933 - $465,689
275,556 New
275,556 $309,000

Others Institutions Holding MREO

# of Institutions
86
Shares Held
107M
Call Options Held
209K
Put Options Held
479K
View Full List

About Mereo Biopharma Group plc

MREO Quotes by TradingView
  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $376M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email